Page 56 - Occupational Health & Safety, March 2018
P. 56

BREAKTHROUGH STRATEGIES
BY ROBERT PATER
Cascading Effects:
Preventing Addiction with Safety
What we as leaders do and don’t can go well beyond just affecting organizational members’ work life; it can also impact their Wpersonal lives.
ise leaders deeply understand there are connections between events that aren’t obviously apparent. That the actions they take at the workplace and those they don’t both have effects that can reach far beyond the
immediate life of their organization.
Likely everyone knows there’s an opioid addiction problem in
the United States (some would use the word “crisis”). On Dec. 1, 2017, noted health educator Dr. Joseph Mercola, D.O., wrote, “Opi- oids are now the leading cause of death among Americans under the age of 50, and more than 202,600 Americans died from over- dosing on these potent pain killers between 2002 and 2015 alone.”
While this is tragic of course, some safety leaders might ask what it has to do with them. Mercola reveals, “Back pain is one of the most common health complaints across the globe, and the No. 1 cause of job disability. It’s also one of the most common reasons triggering opioid dependence, the side effects of which can be le- thal.” Cascading effects again—back pain might lead to death.
Mercola is corroborated by a study done by Richard A Deyo, M.D., MPH, professor of Family Medicine, Oregon Health and Sci- ence University: “Back pain affects most adults, causes disability for some, and is a common reason for seeking healthcare. In the United States, opioid prescription for low back pain has increased, and opioids are now the most commonly prescribed drug class. More than half of regular opioid users report back pain.”
Further, as anyone who’s experienced back pain knows—and every statistic I’ve seen corroborates this is about 80 percent of the adult U.S. population—it’s debilitating and more, often color- ing every action and moment. The North American Spine Society paints a vicious cycle: “Pain can cause stress, which causes more pain, which causes more stress, and so on.” The classic study “Psy- chologic Factors in Low Back Pain Disability,” by luminaries John Frymoyer, M.D., Malcolm Pope, M.D., and others, documented the strong correlations between disabling lower back pain and a slew of negative states, such as “hopeless,” “worried,” “nervous,” “an- noyed,” “temper outbursts,” “unsympathetic,” “sleep disturbances,” “feel miserable,” and much more. The study also showed that even those with “non-disabling lower back pain” had similar reactions (though not to the same degree). For this group, the top reported reactions were “unsatisfied with medical care,” “annoyed,” “sleep disturbances,” and “worried.”
So what that means is the domino effects of back pain can not only lead to drug dependence, but to adverse mental states that can affect work and co-workers, customers, and worse. Of course, there are several other contributors involved, including less-than-effective medical decision-making and/or oversight on pain treatment. And note that there are a slew of non-opioid treatments available for ex-
isting back and other pain from non- opioid pain relievers. (For example, Dr. Mercola is a strong proponent for the right kinds of physical exercise, citing numerous studies to its effectiveness.) And pain clinics offer a range of other mental and physical options.
Further, when it comes to lower
back pain, opioids aren’t even effec-
tive! According to Deyo, “Opioids do
not seem to expedite return to work
in injured workers or improve func-
tional outcomes of acute back pain in
primary care.” Numerous other studies
concur. For example, Manchikanti and
others wrote, “Overall, it appears that
epidemiological studies report the fail-
ure of opioids to improve QOL (Qual-
ity of Life) in chronic pain patients. By
contrast, Eriksen et al. demonstrated
worse pain, higher health care utilization and lower activity levels in opioid-treated patients. . . . Instead of improving functional sta- tus, opioid use has been associated with increased disability, medi- cal costs, subsequent surgery and continued or late opioid use.” In essence, back pain can lead to opioid use, which can lead to greater lost workdays and more workers’ comp issues.
But for Safety leaders, doesn’t it make sense that preventing the incidence and severity of lower back pain in the first place can not only reduce workers’ comp injuries, but also potentially sidetrack as- sociated drug-dependence problems? Of course, like much of safety, some of the best results may turn out to be what doesn’t occur.
Overall, what we as leaders do and don’t can go well beyond just affecting organizational members’ work life; it can also im- pact their personal lives. Finding ways to actually head off lower back problems and other severe soft-tissue injuries may dra- matically forestall other, perhaps even more significant issues. The bottom-line keys? An artful mix of simple modifications, high-level skills training, and activating everyone toward atten- tive decision-making. Experience with numerous organizations shows this is clearly possible to do! (See my numerous articles in previous Occupational Health & Safety issues for much more on how to practically accomplish this.)
If you ever find yourself doubting whether you are making a difference, whether it’s worth putting up with the stresses of wading through resistance or complacency in your organization, whenever frustrations mutate into feeling unappreciated—remind yourself ! By actually reducing the incidence and severity of lower back and other soft-tissue injuries, leaders can go beyond reducing workers’ comp injuries and controlling costs, toward dramatically improv- ing the quality and even lengthening the lives of many.
Robert Pater is managing director and founder of Strategic Safety Associates/MoveSMART®, www.movesmart.com.
50 Occupational Health & Safety | MARCH 2018
www.ohsonline.com
Doesn’t it make sense that pre- venting the incidence and severity of lower back pain in the first place can not only reduce work- ers’ comp injuries, but also potentially sidetrack associ- ated drug-depen- dence problems?
































































   54   55   56   57   58